PISANTI, Simona
 Distribuzione geografica
Continente #
AS - Asia 4.393
NA - Nord America 2.547
EU - Europa 1.074
SA - Sud America 138
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.160
Nazione #
HK - Hong Kong 3.486
US - Stati Uniti d'America 2.524
IT - Italia 299
CN - Cina 296
SG - Singapore 291
RU - Federazione Russa 200
VN - Vietnam 165
UA - Ucraina 154
DE - Germania 134
BR - Brasile 126
SE - Svezia 91
IE - Irlanda 66
TR - Turchia 59
FI - Finlandia 50
KR - Corea 38
IN - India 23
CZ - Repubblica Ceca 22
GB - Regno Unito 22
CA - Canada 11
BD - Bangladesh 8
AT - Austria 7
ES - Italia 7
MX - Messico 7
IQ - Iraq 5
AR - Argentina 4
BE - Belgio 4
CH - Svizzera 3
EC - Ecuador 3
ID - Indonesia 3
IL - Israele 3
JP - Giappone 3
SK - Slovacchia (Repubblica Slovacca) 3
EG - Egitto 2
EU - Europa 2
JM - Giamaica 2
LT - Lituania 2
PL - Polonia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
FR - Francia 1
GE - Georgia 1
JO - Giordania 1
KH - Cambogia 1
NL - Olanda 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 8.160
Città #
Hong Kong 3.484
Ann Arbor 690
Chandler 339
Woodbridge 249
Princeton 186
Jacksonville 181
Dong Ket 158
Singapore 121
Wilmington 98
Houston 97
Ashburn 75
Munich 74
Beijing 72
Dublin 66
Salerno 58
Izmir 55
Nanjing 55
Boardman 45
Andover 43
Naples 39
Pellezzano 29
Moscow 27
Brno 22
Shenyang 22
Fairfield 18
Shanghai 18
Dallas 15
Los Angeles 15
Norwalk 14
Mestre 13
Pune 13
Turku 13
Jiaxing 12
Seattle 12
Changsha 11
Dearborn 11
Hebei 11
Nanchang 11
São Paulo 11
Fisciano 9
Helsinki 9
Jinan 9
Zhengzhou 9
Düsseldorf 8
Nürnberg 8
Cambridge 7
Columbus 7
Falls Church 7
Rome 7
San Francisco 7
The Dalles 6
West Jordan 6
Belo Horizonte 5
Bengaluru 5
Boston 5
Brasília 5
Domicella 5
Guangzhou 5
Qualiano 5
Redwood City 5
Santa Clara 5
Bari 4
Brussels 4
Casagiove 4
Catania 4
Lanzhou 4
San Diego 4
San Nicola la Strada 4
Sarno 4
Settimo Milanese 4
Tianjin 4
Warrington 4
Washington 4
Betim 3
Birmingham 3
Bologna 3
Carney 3
Hefei 3
Lappeenranta 3
London 3
Madrid 3
Milan 3
New York 3
Nuremberg 3
Secaucus 3
Serang 3
Tokyo 3
Vienna 3
Wuhan 3
Ancona 2
Ankara 2
Baghdad 2
Brescia 2
Brooklyn 2
Cairo 2
Campina Grande 2
Campinas 2
Caserta 2
Casoria 2
Castellammare Di Stabia 2
Totale 6.745
Nome #
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis 1.229
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. 923
The endocannabinoid signaling system in cancer 846
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux 259
Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19 245
Pharmacological actions of statins: a critical appraisal in the management of cancer. 214
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation 204
The isoprenoid derivative N6-benzyladenosine (CM223) exerts antitumor effect in glioma patient-derived primary cells through the mevalonate pathway 199
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor. 172
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation 146
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration. 141
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells. 141
Gene Expression Analysis of Mevalonate Kinase Deficiency Affected Children Identifies Molecular Signatures Related to Hematopoiesis 137
Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma 123
Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. 122
Anandamide inhibits adhesion and migration of breast cancer cells. 121
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells 120
Cannabidiol: State of the art and new challenges for therapeutic applications 118
Dental care and dentistry practice in the Medieval Medical School of Salerno 117
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 113
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. 112
p53 regulates the mevalonate pathway in human glioblastoma multiforme. 110
“Adiponcosis”: A New Term to Name the Obesity and Cancer Link 109
Antiangiogenic activity of the endocannabinoid anandamide. Correlation to its tumour-suppressor efficacy 99
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. 97
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity. 94
Couroupita guianensis bark decoction: From Amazonian medicine to the UHPLC-HRMS chemical profile and its role in inflammation processes and re-epithelialization 90
The basis of the modern medical hygiene in the medieval Medical School of Salerno 87
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state. 86
Cannabinoids and cancer: pros and cons of an antitumour strategy. 80
Modern History of Medical Cannabis: From Widespread Use to Prohibitionism and Back 80
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon 79
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. 78
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents 74
3-hydroxytyrosol promotes angiogenesis in vitro by stimulating endothelial cell migration 73
Trotula e le piante medicinali mediterranee: dal Medioevo alla cosmetologia moderna 71
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells. 71
Ganoderma lucidum ethanol extracts enhance re-epithelialization and prevent keratinocytes from free-radical injury 71
Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. (review) 68
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. 67
The medieval skincare routine according to the formulations of Madgistra Trotula and the Medical School of Salerno and its reflection on cosmetology of the third millennium 66
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. 65
Novel prospects of statins as therapeutic agents in cancer 64
Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients 64
N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice 63
Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines 63
Psychological Stress and Cancer: New Evidence of An Increasingly Strong Link 61
The complex interplay among hepatocytes and immune cells at the crossroad between inflammation and cholesterol metabolism in hyperglycemia 54
null 50
Medicinal use of cannabis in Europe: The fact that more countries legalize the medicinal use of cannabis should not become an argument for unfettered and uncontrolled use 49
Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer". 46
Keratinocytes migration promotion, proliferation induction, and free radical injury prevention by 3-hydroxytirosol 46
β -Lactoglobulin Heptapeptide Reduces Oxidative Stress in Intestinal Epithelial Cells and Angiotensin II-Induced Vasoconstriction on Mouse Mesenteric Arteries by Induction of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Translocation 42
Activity of Colocasia esculenta (Taro) Corms against Gastric Adenocarcinoma Cells: Chemical Study and Molecular Characterization 41
Anticancer Activity and Mechanism of Action of Couroupita guianensis Bark Decoction in Gastric Adenocarcinoma Cancer Cell Line 40
Tumor-Associated Macrophage Status in Cancer Treatment 32
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 27
Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients 21
Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines 16
Mangostanin, a Xanthone Derived from Garcinia mangostana Fruit, Exerts Protective and Reparative Effects on Oxidative Damage in Human Keratinocytes 16
Totale 8.312
Categoria #
all - tutte 22.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.748


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021461 0 31 33 10 33 24 39 10 41 6 52 182
2021/2022353 2 6 0 10 27 7 2 16 57 41 45 140
2022/2023699 56 69 19 101 87 118 8 74 94 12 38 23
2023/2024326 28 37 18 9 22 52 13 23 9 24 33 58
2024/2025992 44 10 46 65 58 79 207 56 123 35 124 145
2025/20263.617 2.284 1.333 0 0 0 0 0 0 0 0 0 0
Totale 8.312